帕金森病中的QT间隔:系统性审查
1Division of Cardiology, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Journal of geriatric cardiology : JGC
|November 1, 2024
概括
患有帕金森病 (PD) 的个人表现出延长的QT间隔,表明心脏风险增加. 这种QT间隔延长与PD严重程度有关,可能需要在患者评估和治疗策略中加以考虑.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 临床电生理学 临床电生理学
背景情况:
- 帕金森病 (PD) 与死亡的风险增加了一倍,特别是突然心脏病死亡.
- 延长QT间隔是心脏突然死亡的已知危险因素.
- 需要进一步调查QT间隔和PD之间的关系.
研究的目的:
- 评估QT间隔与帕金森病之间的潜在关联.
- 确定QT间隔延长是否在患有PD的个体中更为普遍.
- 探索QT间隔和PD严重程度之间的相关性.
主要方法:
- 使用Medline和EMBASE进行了系统的文献搜索.
- 搜索术语包括"PD"",QT间隔"和"心脏再极化".
- 分析了7项涉及981名患有PD的参与者和对照组的相关研究.
主要成果:
- 与对照组相比,患有PD的个体表现出明显更长的QT间隔 (10.7 ± 2.8毫秒).
- 几率比率表明PD患者的QTc延长2.6倍 (P < 0.001).
- 在QT间隔持续时间和PD严重程度 (Hoehn-Yahr分类,P = 0.004) 之间发现了显著的相关性.
结论:
- 患有PD的个体比没有PD的人具有更长的QT间隔.
- QT 间隔延长与PD 严重程度和进展的增加有关.
- QT 间隔可能是PD评估的有价值标记,也是潜在的治疗目标.
相关概念视频
Parkinson's Disease: Overview
483
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
483
Parkinson's Disease: Treatment
224
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
224
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
914
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
914
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
193
Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
193


